dual mTOR complex-1/2 inhibitor (University of Pennsylvania/University of Pittsburgh)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual mTOR complex-1/2 inhibitor (University of Pennsylvania/University of Pittsburgh)
Drug Alias NamePP-242 (University of Pittsburgh)PP-242
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionmTOR Complex 2 inhibitorsMammalian target of Rapamycin (mTORC1) inhibitors
TargetsMammalian target of Rapamycin (mTORC1)mTOR Complex 2
Therapy Area/IndicationsPulmonary Arterial HypertensionPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of PittsburghUniversity Of Pennsylvania
Active IndicationsN/A
Inactive IndicationsPulmonary Arterial HypertensionPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma

Other Information

ATC CodeN/A
Related LinksN/A